Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.


AHA responds to CDC RFI on the potential use of ICD-11 for morbidity coding in the U.S.
AHA comments regarding the ongoing government funding discussion, AHA Urges Congress to eliminate Medicaid DSH cuts, reject Site-neutral payments.
The Honorable Chiquita Brooks-LaSure Administrator Centers for Medicare & Medicaid ServicesHubert H. Humphrey Building 
AHA comments on the CMS proposed rule for policy and technical changes to the Medicare Advantage program in contract year 2025.
AHA shares comments and ask that commissioners consider the following issues before making their final payment update recommendations at the upcoming Medicare Payment Advisory Commission (MedPAC) meeting.
AHA provides comments to the Centers for Medicare & Medicaid Services and the Office of the National Coordinator for Health Information Technology on their proposed rule to establish disincentives for providers found to have committed information blocking.
AHA comments on the SUPPORT for Patients and Communities Reauthorization Act.
AHA expresses support for the SUPPORT for Patients and Communities Reauthorization Act (H.R. 4531).
AHA comments regarding provisions in the Lower Costs, More Transparency Act (H.R. 5378).
AHA letter expressing concern about a reduction of over 40% in reimbursement for hyperbaric oxygen therapy (HBOT) that was published in the Centers for Medicare & Medicaid Services’ (CMS) hospital outpatient prospective payment system (OPPS) final rule for calendar year (CY) 2024.